Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Hendlisz

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Clinical & Experimental Metastasis|July 15, 2023
Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancerAli Bohlok, Camille Tonneau, Sophie Vankerckhove, et al.
Cells|November 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug ResistancePashalina Kehagias, Nadège Kindt, Mohammad Krayem, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 19, 2021
The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysisDeborah J Repullo, Sandrine Barbois, Daniel Leonard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumoursAhmad Awada, Alain Hendlisz, Olaf Christensen, et al.
BMC Cancer|April 5, 2019
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trialFrançoise Rothé, Marion Maetens, Ghizlane Rouas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2019
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter studyHugo Levillain, Ivan Duran Derijckere, Lieveke Ameye, et al.
Clinical Nuclear Medicine|June 24, 2024
177 Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors : Data From the Prospective Phase 2 LUMEN StudyMagdalena Mileva, Camille Van Bogaert, Gwennaëlle Marin, et al.
Cancers|December 23, 2023
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal CancerIrene Assaf, Danai Fimereli, Geraldine Anthoine, et al.
BMC Cancer|June 3, 2014
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN studyAmelie Deleporte, Marianne Paesmans, Camilo Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancerEric Van Cutsem, Marc Peeters, Salvatore Siena, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Clinical & Experimental Metastasis|July 15, 2023
Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancerAli Bohlok, Camille Tonneau, Sophie Vankerckhove, et al.
Cells|November 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug ResistancePashalina Kehagias, Nadège Kindt, Mohammad Krayem, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 19, 2021
The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysisDeborah J Repullo, Sandrine Barbois, Daniel Leonard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumoursAhmad Awada, Alain Hendlisz, Olaf Christensen, et al.
BMC Cancer|April 5, 2019
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trialFrançoise Rothé, Marion Maetens, Ghizlane Rouas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2019
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter studyHugo Levillain, Ivan Duran Derijckere, Lieveke Ameye, et al.
Clinical Nuclear Medicine|June 24, 2024
177 Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors : Data From the Prospective Phase 2 LUMEN StudyMagdalena Mileva, Camille Van Bogaert, Gwennaëlle Marin, et al.
Cancers|December 23, 2023
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal CancerIrene Assaf, Danai Fimereli, Geraldine Anthoine, et al.
BMC Cancer|June 3, 2014
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN studyAmelie Deleporte, Marianne Paesmans, Camilo Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancerEric Van Cutsem, Marc Peeters, Salvatore Siena, et al.
Pageof 14